Weaver C. Barksdale & Associates’s MetLife MET Stock Holding History
Bought
Maintained
Sold
Other funds holding MET
Weaver C. Barksdale & Associates's MET Position: Q2 2026 in Review
Weaver C. Barksdale & Associates reduced its MetLife (MET) stake by 0.1% in Q2 2026, selling an estimated $1.77K and leaving 22,001 shares worth $1.86M. The position accounts for 1.67% of the portfolio, ranked #30.
Weaver C. Barksdale & Associates first reported a position in MET in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.4M in Q4 2022. 1,446 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Weaver C. Barksdale & Associates held 22,001 shares of MetLife worth $1.86M as of Q2 2026.
- Weaver C. Barksdale & Associates sold 22 MetLife shares in Q2 2026, an estimated $1.77K.
- MetLife made up 1.67% of Weaver C. Barksdale & Associates's portfolio in Q2 2026, its #30 holding.
- Weaver C. Barksdale & Associates first reported a position in MetLife in Q4 2021 and has held it in 19 quarters since.
- Weaver C. Barksdale & Associates's MetLife position peaked at $2.4M in Q4 2022.
- 1,446 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.